{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:08:20Z","timestamp":1793621300350,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Oxidative stress is considered to be part of the pathogenic mechanism for community-acquired pneumonia (CAP) and is closely linked to inflammation. Attenuation of oxidative stress would be expected to reduce pulmonary damage. Antioxidants have been found to be effective in alleviating lung injury and protecting against damage of other organs.<\/jats:p>\n            <jats:p>The aim of the study was to compare the effect of adding N-acetylcysteine (NAC) to conventional treatment versus conventional treatment on oxidative stress, inflammatory factors, and radiological changes in CAP patients.<\/jats:p>\n            <jats:p>Eligible CAP patients at Weihai Municipal Hospital were stratified and randomly assigned to either NAC group or non-NAC group between August 2016 and March 2017. The NAC group received conventional treatment for pneumonia and NAC (1200\u200amg\/d). Thenon-NAC group received conventional therapy. malondialdehyde (MDA), superoxide dismutase (SOD), total antioxidant capacity (TAOC), tumor necrosis factor-\u03b1 (TNF-\u03b1), and computed tomography (CT) images were evaluated at baseline and after treatment. The primary endpoint indicators were the changes in oxidative stress parameters (MDA, TAOC, SOD) and TNF-\u03b1 after treatment in the NAC group compared with those in the non-NAC group. The secondary endpoint indicator was any difference in CT scores after treatment in the NAC group compared with the non-NAC group.<\/jats:p>\n            <jats:p>Baseline levels of MDA, TAOC, SOD, and TNF-\u03b1 were similar between the 2 groups before treatment. Plasma levels of MDA and TNF-\u03b1 decreased more (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05 MDA:p 0.004, TNF-\u03b1:p &lt;0.001) in the NAC group than the non-NAC group, and there was a reliable increase in TAOC content (p 0.005). There was no significant difference in increased plasma SOD activity between the groups (p 0.368), and the NAC group did not show a greater improvement from CT scores. No NAC-related adverse effects were observed.<\/jats:p>\n            <jats:p>Addition of NAC therapy for CAP patients reduced MDA and TNF-\u03b1 and increased TAOC. Treatment with NAC may help to reduce oxidative and inflammatory damage in pneumonia patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013087","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T21:26:40Z","timestamp":1541539600000},"page":"e13087","source":"Crossref","is-referenced-by-count":109,"title":["N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia"],"prefix":"10.1097","volume":"97","author":[{"given":"Qianwen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University"},{"name":"Department of Respiratory, Weihai Municipal Hospital, Weihai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanrong","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Medical Imaging Research Institute Affiliated to Shandong University, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1164\/rccm.201010-1755OC","article-title":"Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis","volume":"183","author":"Hosakote","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1165\/rcmb.2012-0161OC","article-title":"Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization","volume":"47","author":"Kratzer","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejcdt.2013.02.012","article-title":"High dose N-acetyl cysteine improves inflammatory response and outcome in patients with COPD exacerbations","volume":"62","author":"Mahmoud Abd El Hafiz","year":"2013","journal-title":"Egypt J Chest Dis Tubercul"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1399-3003.2000.016003534.x","article-title":"Oxidative stress and regulation of glutathione in lung inflammation","volume":"16","author":"Rahman","year":"2000","journal-title":"Eur Respir J"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/j.jss.2009.08.005","article-title":"Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress","volume":"167","author":"Andrades","year":"2011","journal-title":"J Surg Res"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"426740","DOI":"10.1155\/2014\/426740","article-title":"Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15412555.2014.898040","article-title":"Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine","volume":"11","author":"Santus","year":"2014","journal-title":"COPD"},{"key":"R8-20230915","first-page":"425","article-title":"Role of N-acetylcysteine in the management of COPD","volume":"1","author":"Sadowska","year":"2006","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R9-20230915","first-page":"12","article-title":"Effect of oral N-acetylcysteine in COPD - a randomised controlled trial","volume":"14","author":"Bachh","year":"2007","journal-title":"JK-Practitioner"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/08958370304454","article-title":"The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types","volume":"15","author":"Dick","year":"2003","journal-title":"Inhal Toxicol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-152-10-201005180-00017","article-title":"High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia","volume":"152","author":"Lai","year":"2010","journal-title":"Ann Intern Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1378\/chest.08-1216","article-title":"Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia","volume":"135","author":"Lisboa","year":"2009","journal-title":"Chest"},{"issue":"(suppl)","key":"R14-20230915","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R15-20230915","first-page":"537","article-title":"Total antioxidant capacity and C-reactive protein levels in patients with community-acquired pneumonia","volume":"38","author":"Akkaya","year":"2008","journal-title":"Turk J Medicalences"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10753-014-9840-2","article-title":"Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia","volume":"37","author":"Fernandez-Botran","year":"2014","journal-title":"Inflammation"},{"key":"R17-20230915","first-page":"2","article-title":"Preliminary compilation and application of the scale for assessing the absorption of pneumonia in chest radiographs","volume":"11","author":"Yin","year":"2012","journal-title":"Chin J Respir Crit Care"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"e93885","DOI":"10.1371\/journal.pone.0093885","article-title":"Association of radiologic findings with mortality in patients with avian influenza H7N9 pneumonia","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-5231(21)00745-0","article-title":"Slowly resolving, chronic, and recurrent pneumonia","volume":"12","author":"Kirtland","year":"1991","journal-title":"Clin Chest Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jmii.2014.11.005","article-title":"Risk factors for slowly resolving pneumonia in the intensive care unit","volume":"49","author":"Li","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0025-7125(05)70393-X","article-title":"Nonresolving pneumonia and mimics of pneumonia","volume":"85","author":"Rome","year":"2001","journal-title":"Med Clin North Am"},{"key":"R22-20230915","first-page":"185","article-title":"Preliminary compilation and application of pneumonia chest radiograph absorption evaluation scale","volume":"11","author":"Yin","year":"2012","journal-title":"Chin J Respir Crit Care Med"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.rmed.2003.08.015","article-title":"Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia","volume":"98","author":"Majewska","year":"2004","journal-title":"Respir Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.91.2.488","article-title":"Wisconsin cystic fibrosis chest radiograph scoring system","volume":"91","author":"Weatherly","year":"1993","journal-title":"Pediatrics"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4067\/S0716-97602013000200013","article-title":"Relationship between severity of adult community-acquired pneumonia and impairment of the antioxidant defense system","volume":"46","author":"Castillo","year":"2013","journal-title":"Biol Res"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.medin.2013.01.004","article-title":"Oxidative stress in immunocompetent patients with severe community-acquired pneumonia. A pilot study","volume":"38","author":"Trefler","year":"2014","journal-title":"Med Intensiva"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1165\/rcmb.2012-0295OC","article-title":"N-acetylcysteine protects murine alveolar type II cells from cigarette smoke injury in a nuclear erythroid 2-related factor-2-independent manner","volume":"48","author":"Messier","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"775","DOI":"10.18203\/2319-2003.ijbcp20161518","article-title":"Effects of administration of oral n-acetylcysteine on oxidative stress in chronic obstructive pulmonary disease patients in rural population","volume":"5","author":"Kale","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"(NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","volume":"82","author":"Mata","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1745-7254.2006.00264.x","article-title":"N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol Sin"},{"issue":"(suppl)","key":"R32-20230915","first-page":"325","article-title":"Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells","volume":"57","author":"Radomska-Lesniewska","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12931-016-0500-y","article-title":"Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation","volume":"18","author":"Cazzola","year":"2017","journal-title":"Respir Res"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2005.11.003","article-title":"Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: in vivo and in vitro study","volume":"53","author":"Sadowska","year":"2006","journal-title":"Pharmacol Res"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/icvts\/ivu258","article-title":"N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury","volume":"19","author":"Forgiarini","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.rmed.2006.07.017","article-title":"Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury","volume":"101","author":"Nagata","year":"2007","journal-title":"Respir Med"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jss.2017.06.061","article-title":"Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation","volume":"218","author":"Yamada","year":"2017","journal-title":"J Surg Res"},{"key":"R39-20230915","first-page":"278","article-title":"Effect of N-acetylcysteine inhalation on ventilator-associated pneumonia caused by biofilm in endotracheal tubes","volume":"54","author":"Qu","year":"2016","journal-title":"ZhonghuaErKeZa Zhi"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1440-1843.2005.00725.x","article-title":"A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis","volume":"10","author":"Tomioka","year":"2005","journal-title":"Respirology"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/COPD.S49307","article-title":"Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients","volume":"8","author":"De Backer","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R42-20230915","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1378\/chest.11-1446","article-title":"Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia","volume":"141","author":"Menendez","year":"2012","journal-title":"Chest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:08:31Z","timestamp":1694812111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00035"}},"subtitle":["A randomized controlled trial"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013087","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}